FBLN1 and non-small cell lung carcinoma: TCGA and Oncomine data both show FBLN1 (and FBLN3–data not shown) to be downregulated in NSCLC, with significant overexpression of EGFR (Figures 1A–D; Okayama et al., 2012; Selamat et al., 2012; Campbell et al., 2016).